On September 3, 2026, EngiTissue Design Co., Ltd. participated in the ISCT Asia 2026 Regional Meeting (International Society for Cell & Gene Therapy), held at the Suntec Singapore Convention & Exhibition Centre in Singapore.
At the meeting, an abstract by Li Junjun of our company was accepted for an Oral Presentation and delivered in Oral Session 2.
Presentation title: A dual excitation-contraction platform for functional evaluation and drug safety assessment of human iPSC-derived cardiac tissues
In the presentation, using human iPSC (induced pluripotent stem cell)-derived cardiac tissue, we reported a platform for evaluating tissue function and applying it to drug safety assessment. A poster presentation was also given, and we held active discussions with fellow researchers and experts.
EngiTissue Design continues to develop functional and drug-safety evaluation technologies utilizing iPSC-derived tissues. We will keep sharing our research results and building a global network through such international academic exchanges.
Related Publications
- Clinical and experimental insights into hydroxychloroquine-associated electrical abnormalities and cardiomyopathy. https://doi.org/10.1093/ehjcvp/pvag063
- Enabling dual excitation-contraction recording and disease modeling via hydrogel-free heart tissue. https://doi.org/10.1016/j.xcrp.2025.103068
- Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes. https://doi.org/10.1093/hmg/ddab127
- Human pluripotent stem cell-derived cardiac tissue-like constructs for repairing the infarcted myocardium. https://doi.org/10.1016/j.stemcr.2017.09.007
- Human induced pluripotent stem cell-derived closed-loop cardiac tissue for drug assessment. https://doi.org/10.1016/j.isci.2024.108992
- Circulating re-entrant waves promote maturation of hiPSC-derived cardiomyocytes in self-organized tissue ring. https://doi.org/10.1038/s42003-020-0853-0